Eris Lifesciences Limited has informed the Exchange regarding Allotment of 9468 Shares.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has allotted 9,468 equity shares to employees who exercised options under the ESOP-2021 Scheme on July 21, 2025. These shares come from three grant years: 2,648 shares from 2022 grants at Rs. 557.24 each, 4,316 shares from 2023 grants at Rs. 510.32 each, and 2,504 shares from 2024 grants at Rs. 728.16 each. The company's paid-up share capital has increased marginally from Rs. 13.62 crore to Rs. 13.62 crore worth of equity. The dilution is extremely small, representing less than 0.01% of the total share base.
This is a routine ESOP allotment with negligible dilution for existing shareholders. No material impact on stock price or shareholder value is expected.